Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin 2 (IL-2) receptor.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples